Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous midazolam and methadone for ICU sedation
IRCT20160307026950N75Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of midazolam and methadone in Not applicable (not a disease) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Level of sedation, Adverse effects and 1 more. Started Jan 2026; status: completed.
02
Drugs
midazolammethadone
03
Conditions
Not applicable (not a disease)
Beyond the preview
Go deeper on IRCT20160307026950N75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N75.